U.S. Medical Equipment Stock News

Doximity entered this earnings week as a quietly discounted healthcare platform with a P/E below many digital health peers. The stock is no longer quiet. Shares surged about 33% in the first full session after the Q1 2027 report as investors rushed to reprice a business that is pouring money into clinical artificial intelligence while still generating strong profits. The headline is simple: Doximity delivered roughly $157 million of revenue and a 48% adjusted earnings before interest, taxes,...

Ardelyx stock just dropped 17.9% to about US$4, extending a three month slide that has taken roughly 41% off the share price. The hit looks harsh when set against what the company just posted. Q2 product revenue reached US$118 million, led by irritable bowel syndrome with constipation drug IBSRELA at US$86.2 million. The company still reported a loss of US$16.7 million, although that was smaller than in Q1. For a biotech like Ardelyx, the real story now sits in the multi year revenue targets,...

In late July 2026, TriNet Group, Inc. reported second-quarter revenue of US$1,178 million versus US$1,238 million a year earlier, while net income rose to US$53 million from US$37 million and diluted earnings per share from continuing operations increased to US$1.15 from US$0.77. Despite lower revenue for both the quarter and first half, TriNet converted more of its top line into profit and lifted full-year 2026 revenue guidance to US$4.75–US$4.9 billion and diluted net income per share...

Kohl's stock has delivered a 79.0% return over the past year, yet valuation checks still indicate the shares screen as undervalued on several measures. With that backdrop and a recent change in board leadership, investors are weighing whether the current price still reflects a discount to the fundamentals. The 79.0% 1 year return points to a strong rebound in sentiment, which can raise the bar for what counts as good value from here. The appointment of Wendy Arlin as board chair and Niren...

In the past quarter ended June 30, 2026, American Financial Group, Inc. reported second-quarter revenue of US$2,030 million and net income of US$248 million, with diluted earnings per share from continuing operations of US$2.99, alongside a six‑month revenue of US$3,884 million and net income of US$439 million. Over the same period, the company also continued its long-running capital return program, repurchasing 200,231 shares for US$26 million and bringing total buybacks under its 2010...

CF Industries Holdings just delivered one of the punchiest profit prints in the sector, yet the stock slipped about 2% on the day after earnings to around US$114. The market marked the price down. The earnings told a different story. Net income for the quarter landed at US$727 million with basic earnings per share of US$4.73, powered by what management frames as a new, higher mid cycle cash generation profile. Coming into the release, CF Industries Holdings had been treading water over the...

KRR stock has fallen 27.5% over the past year but is still up 69.6% over three years, while valuation checks send mixed signals as the intrinsic value estimate suggests upside and earnings based multiples lean the other way. That split, set against a busy deal pipeline in infrastructure, energy and healthcare, is what current holders and potential buyers are trying to make sense of. KKR’s 69.6% gain over three years highlights how much of the long term value case has already been reflected...

Senseonics Holdings went into this report as a high growth, high expectation diabetes tech stock, and the market clearly liked what it saw. The share price jumped about 36% to US$7.02 the day after earnings, a big move for a medical device company still posting sizeable losses. The headline is simple: strong revenue traction in continuous glucose monitoring and a sharp lift in gross margin grabbed investors’ attention, even though Senseonics reported a net loss of US$36.7 million for the...

Cactus has delivered a 104.5% return over the past five years, yet its current checks send mixed valuation signals, with the Discounted Cash Flow (DCF) estimate pointing to upside while earnings-based multiples point to a richer price tag. The 104.5% five year return sets a high bar for new buyers and raises the question of how much future performance is already reflected in the share price. Recent earnings strength can support higher expectations for cash generation, although any pressure...

NeoGenomics earnings shift puts Q2 profitability in focus NeoGenomics (NEO) returned to profitability in the second quarter of 2026, reporting net income of US$2.24 million on sales of US$201.66 million, compared with a net loss a year earlier. See our latest analysis for NeoGenomics. At a share price of US$16.57, NeoGenomics has seen strong momentum build over 2026, with a 90 day share price return of 84.93% and a 1 year total shareholder return of 185.69%. This reflects shifting...

Open Text came into this earnings print with a stock that had quietly climbed over the past month, then gave back ground as shares fell about 3% in the first session after results. The long term thesis centers on a cash generative software platform that pays investors a dividend and trades on a single digit P/E. The headline from this quarter is profit strength. Adjusted EBITDA margin sat in the mid 30s, free cash flow reached about US$808m for the year and net margin over the last twelve...

CRA International stock gave back 4.1% the day after posting what management called record second quarter results. That gap between a softer share price and stronger reported fundamentals is the story investors need to unpack. CRA International booked revenue of US$210.8m for Q2, the highest quarterly level in its history, with basic earnings per share of US$2.13. The company also flagged record first half non GAAP earnings before interest, tax, depreciation and amortization. The full picture...

nCino has had a difficult run for shareholders over the past five years, yet recent product news around its Mortgage MCP platform sits against a valuation picture that screens as somewhat expensive on market multiples and only mixed on broader checks. The share price is down 69.0% over the past five years, which puts extra pressure on any case that the current valuation leaves room for recovery. The launch of Mortgage MCP, which connects AI agents directly to the nCino Mortgage Suite, can...

Beyond Meat (BYND) is back in the spotlight after reporting second quarter 2026 results that swung to a net profit, alongside fresh revenue guidance and new leadership moves at both the executive and board level. See our latest analysis for Beyond Meat. Despite the switch back to profitability, Beyond Meat’s 1 year total shareholder return is down 79.79% and the share price is down 38.99% year to date. A 90 day share price decline of 35.46% highlights that recent earnings and leadership...

With long term unemployment falling for worrying reasons and labor force participation back to early 2021 levels, the job market looks stronger on the surface than it really is. Healthcare is one of the few areas still adding jobs, which can concentrate both risk and opportunity. This article walks through 3 healthcare sector stocks from the screener that are closely tied to this jobs story and explains why they may deserve a closer look. The stocks covered below are just a small sample from...

Kingstone Companies stock just gave back 8.5% in a single session, even as the insurer posted what management called the most profitable quarter in its history. The market is trading the headline price drop. The earnings print centers on a different headline, a 70.2% combined ratio and US$15.5m in net income that indicate significant underwriting profitability for a regional carrier of this size. Coming into today, Kingstone had already logged a strong 90 day run. The key issue now is whether...

After a weak July jobs report showed the U.S. economy losing 23,000 positions and easing pressure on the Federal Reserve to lift rates further, dividend growth stocks suddenly look more interesting to investors hunting for reliable income and potential stability. Lower yields have helped push major indexes to record levels, and that can create a fear of missing out. This article walks through three dividend growth stocks exposed to this shifting rate story and explains how the recent news...

Dentsply Sirona walked into this quarter with a turnaround label and a cheap stock narrative. The share price dropped 8% to about US$12 after the release, yet the headline from the numbers is quieter and more mixed than that move suggests. Revenue came in at US$898m and adjusted earnings per share held at US$0.52, helped by a one off tariff refund. For a company still carrying losses on a trailing twelve month basis, this update was less about a clean reset and more about whether the early...

Cheniere Energy Partners just delivered one of those quarters that makes the share price move look out of step with the story. The stock is down about 1.8% since the earnings release, yet Q2 landed with US$2.40 in basic earnings per unit on US$2.58b of revenue and a trailing P/E sitting around 10.8x. For an LNG export partnership often viewed as a mature, yield focused vehicle with balance sheet questions, the headline this quarter is simple: profitability remains solid while the valuation...

TETRA Technologies, Inc. reported past second-quarter 2026 results, with sales rising to US$185.66 million from US$173.87 million a year earlier, while net income eased to US$10.24 million and diluted EPS from continuing operations slipped to US$0.07 from US$0.08. The combination of higher revenue but lower profitability highlights cost and margin pressures that matter for how investors assess TETRA’s evolving earnings profile. We’ll now examine how this mix of rising sales but softer...

Applied Optoelectronics stock jumped 9% to US$135.44 into the earnings close, which suggests investors were leaning bullish before they even read the fine print. The headline is simple. The company reported record Q2 revenue of US$191.9m and moved to non GAAP profitability with US$5.5m in net income. For a stock that has swung sharply over the past three months, that combination of rapid top line growth and a clean non GAAP profit is the kind of result that can significantly influence...

Roivant Sciences stock has been grinding higher for months, then tacked on another 3.5% after the latest earnings, even as the headline numbers flipped from a quarterly profit to a fresh loss. The market is cheering a biopharma story that is still all about the balance sheet. Cash sits just under US$4.0b and reported operating spending in research and development and general and administrative runs at roughly US$300m for the quarter. The sentiment test now is simple: Are investors paying up...

HA Sustainable Infrastructure Capital shares jumped 6.3% to US$40.66 in the first full session after earnings, and the move speaks directly to one thing: the market is repricing the earnings power rather than the asset base. Adjusted earnings of US$200 million for the first half and adjusted return on equity above 15% put profit quality at the center of this reaction. The key question for you is whether that one-day surge fully reflects the upgraded 2028 earnings outlook or if sentiment is...

Kodiak Gas Services came into this print with a rich 75.4x trailing P/E and a stock that had slipped roughly 14% over the past month. After Q2 earnings, the share price jumped 5.4% to US$59.94. The market finally leaned into the story instead of the skepticism. The hook is simple. This was a quarter about operating power in an asset heavy energy services business. Revenue reached US$391.1m and adjusted EBITDA hit a record US$217m, backed by a 98.2% utilized compression fleet and solid early...